❄️ Happy Holidays from Creyos! As we reflect on the past year, we’re honored to play a small role in how you’re delivering care to your patients. Wishing you, your team, and your loved ones health and happiness this holiday season, and a bright year ahead. #HappyHolidays #HealthcareHeroes #PatientCare
Creyos
Hospitals and Health Care
Toronto, Ontario 20,616 followers
Making cognitive and behavioral health assessment accurate, efficient, and easy.
About us
Creyos (formerly Cambridge Brain Sciences) is a leading web-based platform for the assessment of brain health. It allows you to obtain accurate, quantified and scientifically-validated measures of key aspects of cognition, including short-term memory, attention, reasoning, and verbal ability. Creyos offers two core products – Creyos Health and Creyos Research. Built for health care practitioners, Creyos Health is an online brain health assessment service that takes seconds to set up, is engaging and enjoyable for patients, and produces a reliable and scientifically-validated cognitive assessment report in as little as 15 minutes. It is used by leading health care clinics around the world to track brain health over time as part of cognitive treatment and wellness plans. Healthcare providers using Creyos Health also have access to digital versions of many standardized patient health questionnaires. Creyos Research is made for researchers running studies on cognition in academic and commercial settings, allowing for the collection of cognitive data at scale. It has been used by many leading institutions, including Baycrest, Pfizer and Roche. Both products allow for assessment customization and online administration, require no expert technical support to administer and enable you to store and manage cognitive data securely in the cloud. Creyos maintains a global normative database of more than 85,000 participants (built off of our larger database of 12+ million completed cognitive tasks) that enables you to derive detailed comparisons of individuals to specific populations. The Cambridge Brain Sciences (now Creyos) cognitive tasks were developed in the laboratory of Dr. Adrian Owen, Canada Excellence Research Chair in Cognitive Neuroscience and Imaging (owenlab.org), over the course of his 25-year career. Over 300 scientific studies have been run to date using our tests, yielding numerous publications in leading academic journals.
- Website
-
http://www.creyos.com
External link for Creyos
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- Toronto, Ontario
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Cognitive Assessment, Tracking Brain Health, Cognitive Health, and Cognitive Testing
Locations
-
Primary
220 King St W
Suite 300
Toronto, Ontario M5H 1K4, CA
Employees at Creyos
Updates
-
Predicting Cognitive Performance from Lifestyle Choices: A New Study in PLOS One. Cognitive health is critical to our overall well-being, influencing everything from professional success to life expectancy. But how do lifestyle factors like sleep, exercise, and social habits shape our cognitive abilities? In a study of over 10,000 participants, Dr. Emily Nichols, PhD, Georgia Nelson, Dr. Conor Wild, and Dr. Adrian Owen OBE, FRS, PhD explored how combinations of lifestyle factors predict cognitive performance using Creyos tasks to measure cognitive function and advanced machine-learning techniques. Key findings include: ✅ Regular sleep (7–8 hours per night) supports better cognitive performance. ✅ Aerobic exercise and social engagement are strongly linked to cognitive health. ✅ Personal combinations of lifestyle choices uniquely predict outcomes in different cognitive domains (e.g., memory vs. reasoning). While no single lifestyle choice can guarantee improved cognition, the growing understanding of what affects cognition leads to better ways to protect brain health. 📖 Read the full study here: https://hubs.li/Q02_PSjF0 #CognitiveHealth #LifestyleMatters #BrainHealth #MachineLearning
-
📝 Advance Care Planning: A Key to Patient-Centered Care Boost the quality of your patient-centered care through enhanced cognitive care delivery and care planning. Screening for and tracking patients’ cognitive function helps guide discussions between patients and their points of care. Improve your care planning workflow for your aging patient population through Creyos tools that: - Include templated materials for increased efficiency - Are aligned with Medicare requirements - Have easy to interpret data presentation - Help manage the full continuum of dementia care 📖 Read more on cognitive care planning and its impact on patients and their caregivers here: https://hubs.li/Q02_PP3q0 #AdvanceCarePlanning #PatientCare #HealthcareInnovation
Advance Care Planning: Advance Directives for Health Care
creyos.com
-
💡 In a recent Forbes article, Robert Pearl, M.D. offers valuable insights into how we can differentiate the real potential of AI in healthcare from the hype surrounding it. He proposes three questions important in evaluating AI tools critically: - Does the technology truly improve patient care? - Is it reliable across diverse clinical situations? - Does it provide tangible, evidence-backed results? Drawing on examples from both past and current AI systems, Dr. Pearl emphasizes the importance of ensuring that these tools align with clinical needs and enhance real-world decision-making. 🧠 AI and machine learning systems are highly effective at processing large datasets to deliver evidence-backed, quantitative clinical insights—such as Creyos's dementia screener, which uses hundreds of thousands of data points to predict cognitive impairment in patients. For a deeper understanding of these questions and the guidance they provide in navigating AI-innovation in healthcare, read the article here: https://hubs.li/Q02-MBdt0
3 Simple Questions To Separate AI Reality From Hype In Medicine
social-www.forbes.com
-
🕒 Beyond the MoCA Test: How to Improve Early Dementia Detection 🎯 The MoCA (Montreal Cognitive Assessment) is a widely-used tool to detect cognitive impairment, but what are its limitations in detecting age-related decline especially as we hone in on the importance of early detection? A study comparing the MoCA and Creyos tests found that patients near the MoCA cutoff—classified as borderline—could be more confidently identified as cognitively impaired or unimpaired using a brief set of Creyos tasks (Sternin, Burns, & Owen, 2019). Clinically, using a more sensitive test enables earlier detection of cognitive impairment, facilitating timely treatment and potentially slowing disease progression. Explore how modern assessments complement, and go beyond, traditional tools like the MoCA in this article: https://hubs.li/Q02-LWMY0 and read the comparative study here: https://hubs.li/Q02-LZBh0.
Beyond the MoCA Test: How to Improve Early Dementia Detection
creyos.com
-
🔍 The Future of Neurology: Enhancing Cognitive Care 🧠 📈 MCI and dementia are on the rise in the US, influenced by lifestyle, systemic issues, and comorbidities. This rise in prevalence highlights the need for improved standards in dementia assessment and care, as traditional tests often impose significant burdens, rely on provider interpretation, and restrict patient access. For neurologists, using innovative digital tools provide objective, efficient, and reliable measurements, supporting better patient outcomes. - Strengthen diagnostic decisions with modern cognitive assessments. - Simplify workflows and reimbursements with EHR-ready tools. - Ensure equitable access while boosting financial sustainability. From early detection to long-term management, cognitive care is vital to addressing rising dementia rates and supporting underserved communities. Explore more strategies to approach these challenges in our ebook, "Advancing Dementia Care In Neurology" here: https://hubs.li/Q02-LWMV0 #Neurology #DementiaCare #DigitalHealth #CognitiveAssessment #HealthEquity
-
💡 How does the U.S. compare to other high-income countries in primary care? A new report from The Commonwealth Fund examines primary care across 11 high-income countries, offering valuable insights on access, quality, and affordability. While the U.S. excels in some areas, there are gaps, particularly in accessibility and decentralized care. Key strategies to help close these gaps in access are to implement digital tools that enable telehealth and to support more comprehensive services at a primary care level. 🔍 Dive into the full report and read more on the strategies to enhance primary care systems: https://hubs.li/Q02-0VDS0
Primary Care in High-Income Countries: How the United States Compares
commonwealthfund.org
-
Is your organization ready to embrace the shift to Merit-Based Incentive Payment Systems (MIPS)? Value-Based Care focuses on delivering high-quality, cost-effective care, with models like MIPS rewarding healthcare providers for achieving these goals. 📊 A key component of quality care is Measurement-Based Care (MBC), which uses objective measures to guide treatment decisions. Digital tools play a vital role in providing these insights, enhancing both the patient experience and practice efficiency. 🔍 Explore how innovative, measurement-based digital tools are driving the transformation to Value-Based Care: https://hubs.li/Q02-0GR40
The Paradigm Shift Towards Merit Based Incentive Payment System (MIPS)
creyos.com
-
The Creyos team is heading to the IHI Forum on Quality Improvement in Healthcare in Orlando, FL next week! The IHI Forum unites healthcare leaders driving improved patient care and outcomes. If you're attending, stop by to discover how providers deliver quality care through accurate and patient-friendly cognitive assessments that deliver accessible, timely, and actionable insights. 👋 See the difference that 30+ years of scientific research make in patient care at Booth #431! #IHI #HealthcareQuality #HealthcareImprovement
-
🎯 Curb overdiagnosis and overmedication of ADHD through accurate, objective testing. - Ensure appropriate treatment tailored to your patient's specific diagnosis. - Prescribe with confidence and minimize unnecessary medication side effects. - Save time, effort, and resources by focusing care on those who truly need it. - Build trust with your patients through reliable, data-driven assessments. Dr. Ozan Toy of Telapsychiatry uses the Creyos ADHD testing protocol to gather objective insights into high confidence ADHD markers. This helps ensure accurate diagnoses and allows him to track medication impact over time. 📖 Read the full case study here: https://hubs.li/Q02-0DfR0